Posts

Showing posts with the label Xyzal

Recent Drug Safety Alerts – Asrar Qureshi’s Blog Post #1125

Image
Recent Drug Safety Alerts – Asrar Qureshi’s Blog Post #1125 Dear Colleagues! This is Asrar Qureshi’s Blog Post 1125 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com . Please email to pharmaveterans2017@gmail.com   for publishing your contributions here. Covid Vaccine Scop Transdermal System Xyzal Zyrtec Preamble Post Marketing Surveillance, Pharmacovigilance, and Adverse Drug Reactions Reporting are tools through which adverse reactions are reported from various parts of the world. The activity is more seriously undertaken in the developed countries. The information thus collected is investigated in detail to see if the adverse reaction was caused by the drug or were other factors involved in the outcome. On the basis of the investigation, the regulatory authorities like USFDA, EMA, TGA etc. issue instructions to add cautions or warnings or black box warnings in the prescribing information or on the pack or b...